Healthcare -
Biotechnology - NASDAQ - US
$ 3.76
-0.529 %
$ 336 M
Market Cap
-8.55
P/E
TRVI - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TRVI - Trevi Therapeutics, Inc.
59.4 M
LAST VALUE
0.00%
2 YEAR CAGR
227.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR